Teradyne (TER) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter rose sharply compared with both the prior quarter and the same quarter a year earlier. The sequential increase was substantial, and the year-over-year gain was even larger.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter rose sharply compared with both the prior quarter and the same quarter a year earlier. The sequential increase was substantial, and the year-over-year gain was even larger.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+40.8%
Change from the immediately preceding quarter.
Year-over-year
+43.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 30, 2025 | $685.7M | +14.3% |
| Jun 29, 2025 | $651.8M | -10.7% |
| Sep 28, 2025 | $769.2M | +4.3% |
| Dec 31, 2025 | $1.1B | +43.9% |
Revenue performance
The reported revenue moved upward, marking the highest level among the four quarters shown in the trailing period.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased significantly. Versus the same quarter one year earlier, revenue also posted a strong gain.
What to watch
The filing context does not provide specific drivers for the revenue change; no watch item is indicated.